Product Information
METHYLPHENIDATE 20 MG TABLET is a generic product labeled by AvPAK, priced at $0.2014 per EA under NDC 50268052915. Its NADAC has been published 324 times since Apr 22, 2020.
FDA first approved this application on Sep 22, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
AvPAKNDC
50268052915
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207416FDA Approved
9/22/2015
TE Code
AB
On Market Since
2/13/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 20 MG TABLET has been published 324 times since Apr 22, 2020, and over the history we have for it it has declined 20.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2014 per EA |
|---|---|
| All-time high | $0.2814 (Dec 16, 2020) |
| All-time low | $0.1079 (Apr 17, 2024) |
| 52-week high | $0.2332 |
| 52-week low | $0.1962 |
| Median price | $0.2070 |
| Average price | $0.2078 |
| Largest weekly change | +108.2% (Aug 21, 2024) |
| Weeks tracked | 324 |
| Tracking since | Apr 22, 2020 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AvPAK manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METHYLPHENIDATE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 20 MG TABLET, manufactured by AvPAK, is $0.2014 per EA (NDC 50268052915), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 20 MG TABLET has declined 20.3%. It has been tracked across 324 weekly CMS publications since Apr 22, 2020.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 20 MG TABLET?
Since Apr 22, 2020, the NADAC for METHYLPHENIDATE 20 MG TABLET has ranged from a low of $0.1079 (Apr 17, 2024) to a high of $0.2814 (Dec 16, 2020), with a median of $0.2070 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 20 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 20 MG TABLET?
METHYLPHENIDATE 20 MG TABLET (NDC 50268052915) is labeled by AvPAK, and CMS classifies it as a generic product.